![Vimal Mehta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vimal Mehta
Oprichter bij
BIOXCEL THERAPEUTICS, INC.
Vermogen: 81 832 $ op 31-05-2026
Profiel
Vimal D.
Mehta is the founder of BioXcel Corp., founded in 2005, serving as Chairman & Chief Executive Officer since 2014.
Dr. Mehta is the founder of BioXcel Therapeutics, Inc., founded in 2017, serving as President, Chief Executive Officer & Director since 2021.
Former jobs include Director at Invea Therapeutics, Inc., Manager-Business Development at CuraGen Corp.
from 1996 to 2002, Senior Vice President-Business Development at Alfasigma UK Ltd. from 2002 to 2006, Assistant Professor at The University of Texas Southwestern Medical Center from 1989 to 1996, and Senior Vice President-Business Development at Jubilant Life Sciences (USA), Inc. from 2006 to 2007.
Education includes a doctorate from the University of Delhi.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 69.942 ( 0,48% ) | 81 832 $ | 31-05-2026 |
Actieve functies van Vimal Mehta
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Oprichter | 29-03-2017 |
BioXcel Corp.
 BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions | Algemeen Directeur | 01-01-2005 |
Eerdere bekende functies van Vimal Mehta
| Bedrijven | Functie | Einde |
|---|---|---|
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs | Directeur/Bestuurslid | 01-01-2023 |
Jubilant Life Sciences (USA), Inc.
 Jubilant Life Sciences (USA), Inc. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Corporate Officer/Principal | 01-01-2007 |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Corporate Officer/Principal | 01-01-2006 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Corporate Officer/Principal | 01-01-2002 |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-1996 |
Opleiding van Vimal Mehta
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
37
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Health Technology |
University of Delhi
 University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jubilant Life Sciences (USA), Inc.
Jubilant Life Sciences (USA), Inc. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Distribution Services |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions | Technology Services |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs | Health Technology |
Kies MarketScreener 
